Despite initially riding momentum carried from Q4 2019, hopes for an IPO window of opportunity and rebound in the first half of 2020 were cut short by the global impact of COVID-19 (coronavirus disease of 2019). This led to 235 deals and US$28.5b in proceeds through the first three months of 2020. Despite the equity…